ILONA KURPAKOV: Open Payments
NPI 1841601069 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,760 in 90 payments from 12 companies in 2025. Trend: 2023 $1,375 · 2024 $1,538 · 2025 $2,760
Food & beverage: $2,760
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 31 | $774 |
| ABBVIE INC. | 19 | $371 |
| Aimmune Therapeutics, Inc. | 5 | $361 |
| Amgen Inc. | 11 | $360 |
| Otsuka America Pharmaceutical, Inc. | 7 | $279 |
| GENZYME CORPORATION | 1 | $150 |
| Incyte Corporation | 1 | $135 |
| Almatica Pharma LLC | 6 | $130 |
| Astellas Pharma US Inc | 3 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
Products named: Auvelity, ZENPEP, REXULTI, OTEZLA, REPATHA, DUPIXENT, Opzelura, LINZESS.
Industry payments across NY — which companies pay providers there.
